High Expression of COL10A1 Is an Independent Predictive Poor Prognostic Biomarker and Associated with Immune Infiltration in Advanced Gastric Cancer Microenvironment

Table 1

Association between COL10A1 expression and different clinicopathological features of human GC.

Characteristic	Low expression of COL10A1	High expression of COL10A1
	187	188
T stage, (%)			<0.001
T1	18 (4.9%)	1 (0.3%)
T2	44 (12%)	36 (9.8%)
T3	78 (21.3%)	90 (24.5%)
T4	45 (12.3%)	55 (15%)
N stage, (%)			0.901
N0	53 (14.8%)	58 (16.2%)
N1	51 (14.3%)	46 (12.9%)
N2	39 (10.9%)	36 (10.1%)
N3	37 (10.4%)	37 (10.4%)
M stage, (%)			1.000
M0	166 (46.8%)	164 (46.2%)
M1	13 (3.7%)	12 (3.4%)
Pathologic stage, (%)			0.012
Stage I	36 (10.2%)	17 (4.8%)
Stage II	45 (12.8%)	66 (18.8%)
Stage III	77 (21.9%)	73 (20.7%)
Stage IV	19 (5.4%)	19 (5.4%)
Gender, (%)			0.884
Female	68 (18.1%)	66 (17.6%)
Male	119 (31.7%)	122 (32.5%)
Age, (%)			0.899
≤65	82 (22.1%)	82 (22.1%)
>65	101 (27.2%)	106 (28.6%)
Histologic grade, (%)			0.095
G1	5 (1.4%)	5 (1.4%)
G2	77 (21%)	60 (16.4%)
G3	98 (26.8%)	121 (33.1%)
H pylori infection, (%)			1.000
No	96 (58.9%)	49 (30.1%)
Yes	12 (7.4%)	6 (3.7%)
Barrett’s esophagus, (%)			0.612
No	122 (58.7%)	71 (34.1%)
Yes	11 (5.3%)	4 (1.9%)
Age,			0.580